Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
EGF61A > G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer
Annals of Oncology, 10/28/09
AuthorLastNameFI et al. – Polymorphism analysis of a simple blood sample is a feasible approach to biomarker analysis and the EGF61A>G polymorphism may influence the effect of first-line XELOX. Consequently, this marker deserves further investigation.
Methods- 68 patients treated with first-line XELOX
- Polymorphism analyses carried out on pretreatment blood samples
- Response evaluated according to the RECIST
- Survival analysis described by Kaplan–Meier method and log-rank testing
- Overall response rate was 38% and median overall survival 19.4 months
- Favorable outcome seen in patients with EGF61A/G genotype compared with combined group of A/A and G/G, with response rates of 57% and 18%, respectively
- Significantly different progression-free survival in favor of A/G group
- TS and ERCC1 genotypes failed to provide any significant impact on outcome
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (≤ 1 cm) invasive breast cancer: Who might be possible candidates for adjuvant treatment?
Breast Cancer Research and Treatment, 12/09/09
Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes
Breast Cancer Research, 12/08/09
DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer
Oncogene, 12/08/09
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer
Oncogene, 12/08/09
Functional membrane androgen receptors in colon tumors trigger pro-apoptotic responses in vitro and reduce drastically tumor incidence in vivo
Molecular Cancer, 12/08/09
Case-control study on beneficial effect of regular consumption of apples on colorectal cancer risk in a population with relatively low intake of fruits and vegetables
European Journal of Cancer Prevention, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


